Patents-Review.com
🔗 Permalink
Assignee profile:

Symphogen A/S

City:

Ballerup

Country:

Denmark

Published Applications:

20

Last publication date:

2023-04-06

Patent Grants:

15

Last grant date:

2024-06-18

Top Inventors for applications by Symphogen A/S

These are the the leading inventors for applications assigned to Symphogen A/S:

Recent patent applications by Symphogen A/S

Symphogen A/S based in Ballerup, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-04-06
US20230105714A1
Chemistry; metallurgy

ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS

 #2 | 2022-12-08 ✅ Patent 12,012,450 granted on 2024-06-18
US20220389100A1
Chemistry; metallurgy

Anti-NKG2A antibodies and compositions

 #3 | 2022-12-01
US20220380470A1
Chemistry; metallurgy

COMBINATION THERAPIES TARGETING PD-1, TIM-3, AND LAG-3

 #4 | 2022-11-17 ✅ Patent 11,834,503 granted on 2023-12-05
US20220363757A1
Chemistry; metallurgy

Anti-lag-3 antibodies and compositions

 #5 | 2022-02-24 ✅ Patent 11,390,676 granted on 2022-07-19
US20220056126A1
Chemistry; metallurgy

Anti-LAG-3 antibodies and compositions

 #6 | 2021-10-14 ✅ Patent 12,252,539 granted on 2025-03-18
US20210317216A1
Chemistry; metallurgy

Anti-FLT3 antibodies and compositions

 #7 | 2021-09-16 ✅ Patent 12,030,942 granted on 2024-07-09
US20210284734A1
Chemistry; metallurgy

Anti-PD-1 antibodies and compositions

 #8 | 2021-09-02 ✅ Patent 11,807,688 granted on 2023-11-07
US20210269532A1
Chemistry; metallurgy

Anti-AXL antibodies and compositions

 #9 | 2021-07-15
US20210214454A1
Chemistry; metallurgy

ANTI-CD40 ANTIBODIES AND COMPOSITIONS

 #10 | 2021-03-11 ✅ Patent 11,634,500 granted on 2023-04-25
US20210070876A1
Chemistry; metallurgy

Anti-CD73 antibodies and compositions

 #11 | 2020-12-31 ✅ Patent 11,939,380 granted on 2024-03-26
US20200407444A1
Chemistry; metallurgy

Combination therapies targeting PD-1, TIM-3, and LAG-3

 #12 | 2020-11-05
US20200347140A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-EGFR ANTIBODIES

 #13 | 2019-12-05 ✅ Patent 11,359,018 granted on 2022-06-14
US20190367616A1
Chemistry; metallurgy

Anti-PD-1 antibodies and compositions

 #14 | 2019-09-12 ✅ Patent 11,390,674 granted on 2022-07-19
US20190276531A1
Chemistry; metallurgy

Anti-TIM-3 antibodies and compositions

 #15 | 2019-05-16 ✅ Patent 11,034,765 granted on 2021-06-15
US20190144542A1
Chemistry; metallurgy

Anti-PD-1 antibodies and compositions

 #16 | 2018-12-06
US20180344846A1
Human necessities

HUMANIZED PAN-HER ANTIBODY COMPOSITIONS

 #17 | 2018-11-15 ✅ Patent 10,450,376 granted on 2019-10-22
US20180327500A1
Chemistry; metallurgy

Anti-MET antibodies and compositions

 #18 | 2017-06-15 ✅ Patent 10,058,610 granted on 2018-08-28
US20170165365A1
Human necessities

Methods for treating cancer by administering humanized pan-HER antibody compositions

 #19 | 2017-06-01 ✅ Patent 10,221,246 granted on 2019-03-05
US20170152322A1
Chemistry; metallurgy

Pan-HER antibody composition

 #20 | 2015-03-26 ✅ Patent 9,527,913 granted on 2016-12-27
US20150086478A1
Chemistry; metallurgy

Humanized pan-HER antibody compositions

Also check out SYMPHOGEN A/S's (Ballerup, Denmark) applicant profile with 10 patent applications submitted.

AssigneeID:

142353 ⎘